The leading global voice
We play a major role in bringing the CV community together to drive transformational change.
Together we are stronger
By 2025, our aim is to reduce premature deaths from CVD by at least 25%.
Join the fight
Become a WHF member and help us to build global commitment to address cardiovascular health at the policy level.
We convene and connect our members
To share science, best practice and resources, acting as a global thought leader and catalyst for positive change.
Celebrate World Heart Day
The biggest global awareness-raising campaign for CVD.
Attend the Congress
Join world leaders in heart health, share ideas, network with specialists.
Advocating for heart health
We lead the global advocacy effort for action to prevent, control and reduce the global burden of CVD.
All our programmes and partnerships are aimed at creating awareness of CVD as a priority issue across the globe.
Find out more about our and our members’ work around the world.
Explore everything from toolkits, videos and infographics, to policy reports, factsheets and more.
Find out more about our and our members' work around the world.
Striving for a 25% reduction in premature mortality
caused by cardiovascular disease by 2025
Home > Global Advocacy > Our 25by25 Objective
To support the broad 25by25 vision for NCDs, the WHO launched a set of targets and indicators in 2014. Achieving these targets, which are found in the Global Monitoring Framework, will have a direct impact on reducing the global burden of CVD.
CVD accounts for 31% of global deaths: this amounts to 17.5 million people losing their lives every year. Over three quarters of CVD deaths take place in low- and middle-income countries, which carry heavy socio-economic burdens associated with CVD.
Beyond these alarming facts and figures, CVD is a devastating, yet often preventable disease, which affects people, families and communities all over the world. Therefore, to reduce the global burden of NCDs and achieve the 25by25 target, it is essential that CVD and its risk factors are addressed.
Agenda 2030 for Sustainable Development: People, Planet and Prosperity
In September 2015, world leaders convened at the United Nations to formally adopt the 2030 Agenda for Sustainable Development; an ambitious global framework to end extreme poverty, eliminate inequality and injustice, improve health outcomes and conserve our planet over the next fifteen years.
Also known as the Sustainable Development Goals (SDGs), the 2030 Agenda succeeds the Millennium Development Goals, which ran from 2000-2015, and comprises 17 major goals supported by 169 targets. Thanks to years of extensive advocacy, health features prominently within the SDGs, as Goal 3 of the Agenda: ‘Ensure healthy lives and promote wellbeing for all at all ages’.
Cardiovascular Disease and Agenda 2030
For the first time in history, non-communicable diseases (NCDs), including cardiovascular disease (CVD), are specifically included in the Agenda as a major development priority. This means that each of the 193 country signatories of the document have committed resources, expertise and collaborative efforts to prevent and control heart disease and other NCDs. Never before have governments been so strongly compelled to act on the global CVD epidemic.
There are three sections of the 2030 Agenda in which NCDs (including CVD) are mentioned explicitly:
While the inclusion of CVD and NCDs in Agenda 2030 is a landmark achievement, our work is far from over. Now, more than ever, governments need to be encouraged and assisted to achieve the new target of reducing NCDs by one third by 2030. A key way to meet this goal is to continue working towards the World Heart Federation’s target of reducing CVD by 25% by 2025, as CVD continues to cause the highest proportion of non-communicable deaths across the world.
At the United Nations High-level Meeting on NCDs in 2018 (HLM 2018), WHO Member States will review their progress on NCDs, both nationally and globally, and towards the 4 time-bound commitments set in 2014.
Given the scale of the global NCD epidemic, progress so far has been inadequate, and urgent action is needed. It is now time to increase the pace in terms of advocacy and campaigning so that countries are compelled to act.
Download the toolkit
WHF9421_Advocacy_toolkit__PDF-4.pdf (848.49 kB)